The ALFF value was derived by averaging the square root values within the frequency range of 0.010.1 Hz [45]
Thota RN, Dias CB, Abbott KA, Acharya SH, Garg ML
Like other incretin-based medications, the most common side effects were gastrointestinal: Common Side Effects Nausea: Reported in approximately 25-45% of participants depending on dose (most common during titration) Diarrhea: Approximately 20-35% of participants Vomiting: Approximately 10-20% of participants Constipation: Approximately 10-15% of participants Decreased appetite: Common and expected given the mechanism of action Less Common but Notable Effects Increased heart rate: Small elevations in resting heart rate were observed, consistent with other GLP-1 class medications Injection site reactions: Mild redness or itching at injection sites Fatigue: Reported by some participants, particularly during dose escalation Most adverse events were mild to moderate and occurred primarily during the dose escalation phase
These medications have these effects: Reducing appetite and increasing feelings of fullness Slowing how quickly food leaves the stomach Improving the bodys response to insulin Together, these effects help people eat less and lose weight over time
J Neurosci 25:88078814 Lee Y-J, Choi D-Y, Yun Y-P, Han SB, Oh K-W, Hong JT (2013) Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties
